Omeros (NASDAQ:OMER - Get Free Report) is scheduled to be announcing its earnings results after the market closes on Wednesday, November 13th.
Omeros Trading Down 0.7 %
Omeros stock traded down $0.03 during midday trading on Tuesday, reaching $4.26. 303,011 shares of the stock traded hands, compared to its average volume of 396,343. The firm has a fifty day moving average price of $4.01 and a two-hundred day moving average price of $4.04. Omeros has a fifty-two week low of $1.17 and a fifty-two week high of $5.68. The firm has a market cap of $246.85 million, a price-to-earnings ratio of -1.83 and a beta of 1.47.
Analyst Upgrades and Downgrades
Separately, StockNews.com raised Omeros from a "sell" rating to a "hold" rating in a research note on Friday, August 16th.
View Our Latest Report on Omeros
Omeros Company Profile
(
Get Free Report)
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases, including complement-mediated diseases, cancers, and addictive and compulsive disorders. The company's products under development include Narsoplimab (OMS721/MASP-2) that has completed pivotal trial for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); that is in Phase III clinical trial for the treatment of immunoglobulin A nephropathy (IgAN); and Phase II clinical trial to treat COVID-19.
Further Reading
Before you consider Omeros, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omeros wasn't on the list.
While Omeros currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
